Skip to main content
OpenTrials

Clinical trial condition

Ovarian Diseases

Explore clinical trials studying Ovarian Diseases. Study availability and eligibility vary by location and protocol.

3,405 public trials 661 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Diseases trial results

Completed

Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT01767675

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
  • Baptist Health South Florida Miami, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors

NCT02923349

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Malignancies, +45 more
Locations
  • Rutgers, The State University of New Jersey New Brunswick, New Jersey, United States
  • New York University Clinical Cancer Center New York, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers

NCT03748186

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +29 more
Locations
  • Arizona Oncology - Tucson Tucson, Arizona, United States
  • UCLA Jonsson Comprehensive Cancer Center Clinical Research Unit Los Angeles, California, United States
  • Sutter Health- Palo Alto Medical Foundation San Francisco, California, United States
  • Rocky Mountain Cancer Center Aurora, Colorado, United States
View all 27 locations
View Trial Details
Completed

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

NCT05259696

Conditions
Adnexal Diseases, Bladder Cancer, Breast Cancer, +68 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
  • Stanford Health Care Stanford, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
View all 13 locations
View Trial Details

Related conditions